myTomorrows is the trade name of Impatients N.V., a globally active healthcare company. The company is based in the

Zuidas The Zuidas (literally ''South Axis'' in Dutch) is a rapidly developing business district in the city of Amsterdam in the Netherlands. The Zuidas is also known as the 'Financial Mile'. It lies between the rivers Amstel and ''Schinkel'' along the ...

Amsterdam Amsterdam ( , , , lit. ''The Dam on the River Amstel'') is the capital and most populous city of the Netherlands, with The Hague being the seat of government. It has a population of 907,976 within the city proper, 1,558,755 in the urban ar ...

Netherlands ) , anthem = ( en, "William of Nassau") , image_map = , map_caption = , subdivision_type = Sovereign state , subdivision_name = Kingdom of the Netherlands , established_title = Before independence , established_date = Spanish Netherl ...

. myTomorrows provides patients with unmet medical needs, and their doctors, information about treatment options worldwide and facilitates access to medicines in development. Access to these medicines can be achieved via clinical trials,

expanded access Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life ...

and

off-label use Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration. Both prescription drugs and over-the-counter drugs (OTCs) can be used in off-label ways, although ...

. myTomorrows was founded in 2012 by Ronald Brus, former CEO of the

biotechnology Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used ...

company

Crucell Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell based in Leiden and placed it in their ph ...

. In the beginning of its existence, myTomorrows has been characterized as ''innovative'' and ''controversial''. In May 2013, MP Lea Bouwmeester asked

parliamentary question A question time in a parliament occurs when members of the parliament ask questions of government ministers (including the prime minister), which they are obliged to answer. It usually occurs daily while parliament is sitting, though it can be ca ...

about the company. In December 2017, former minister

Ronald Plasterk Ronald Hans Anton Plasterk (; born 12 April 1957) is a Dutch scientist, entrepreneur and retired politician of the Labour Party (PvdA). He has earned a PhD degree in biology, specialised in molecular genetics. Being a former Minister of the Du ...

joined the company as Chief Scientific Officer.

References

External links

Official website
2012 establishments in the Netherlands Companies based in Amsterdam Multinational companies headquartered in the Netherlands {{Netherlands-company-stub